课题基金 / 基金详情

NIDCD Core for Clinical Research and Care

NIDCD Core for Clinical Research and Care
NIDCD 临床研究和护理核心
批准号:
10923716
负责人:
Joshua Levy
金额:
$304.96万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AQP1 geneAdministratorAdmission activityAdultAmbulatory Care FacilitiesAppointmentAreaAudiologyCCRCare given by nursesCaringChildChromosome MappingCisplatinClinicalClinical ClerkshipClinical DataClinical InvestigatorClinical ResearchClinical ServicesClinical TrialsClinics and HospitalsCommunication impairmentComplexConsultConsultationsContinuing EducationCredentialingDataData CollectionDatabasesDevelopmentDiseaseDoseEmergency SituationEndoscopyEquilibriumEquipment and SuppliesEvaluationFellowshipFosteringGenesGenetic studyHead and Neck DisorderHead and Neck Squamous Cell CarcinomaHead and Neck SurgeonHearingHearing problemHereditary DiseaseHospital AdministrationHospitalsHourHumanHuman ResourcesImageIndiaInpatientsInstitutional Review BoardsInterventionIntervention StudiesIntramural Research ProgramLaboratoriesLabyrinthMaintenanceMedicalMedical StudentsMentorsMissionMolecularMolecular AnalysisMonitorNational Institute on Deafness and Other Communication DisordersNatural HistoryNeoadjuvant TherapyNurse PractitionersNursing ResearchOlfactory NeuroblastomaOperative Surgical ProceduresOtolaryngologistOtolaryngologyOutpatientsPakistanParotid GlandPathogenesisPatient CarePatient EducationPatientsPhasePhenotypePhysiciansProgram DevelopmentProtocols documentationProviderRecordsRecurrent respiratory papillomatosisResearchResearch SupportResourcesSafetySalivaryScientistServicesSpecimenSpeechSupervisionSurgeonTestingTimeTrainingTravelUnited States National Institutes of HealthVestibular AqueductVisitVoiceWorkadeno-associated viral vectoratorvastatinbevacizumabcareer developmentcisplatin induced hearing lossclinical careclinical implementationdata managementgenetic analysisgenetic deafnessgenome editinghearing impairmenthearing restorationhereditary hearing losshuman papilloma virus oropharyngeal squamous cell carcinomahuman subjectinpatient serviceirradiationmeetingsototoxicityoutpatient programspatient screeningphase 2 studyphotoimmunotherapyprogramsprotocol developmentquality assurancerecruitresponsesymposiumvolunteer

项目摘要

项目成果

Joshua Levy的其他基金

相似基金

相关文献

中文摘要
翻译
NIDCD临床研究和护理核心支持以下NIDCD项目: 1 Zia DC000039综合征性和非综合征性耳聋基因鉴定 1 Zia DC000046人类沟通障碍的遗传学研究 1人遗传性耳聋的Zia DC000060分子分析 1 Zia DC000064听力和平衡障碍临床分析 1个ZIA-DC-000082神经病学项目 1-ZIA-DC-000088成人内耳听力恢复的细胞和分子机制 核心支持的NIDCD和协作协议包括: OH93-DC-0016-非综合征遗传性耳聋基因图谱:印度/巴基斯坦方案 97-DC-0180-遗传性耳聋的遗传分析 01-DC-0228-前庭导水管扩大所致听力障碍的临床和分子分析 01-DC-0229-遗传性听力和平衡障碍的遗传分析 12-DC-0152.听力前庭测试的标准值 17-DC-0138-顺铂和他汀类药物耳毒性 18-DC-0051-NIDCD生物检疫协议 20-DC-0047-遗传性听力损失的自然病史和基因组编辑 21-DC-0002-阿托伐他汀降低顺铂所致听力损失的III期干预研究 21-C-0009--儿童和成人嗅神经母细胞瘤的自然史研究 000077例头颈部疾病的临床资料和标本 000141听力不稳定表型 15-D-0129剂量递增研究评价单次注射携带人水通道蛋白-1基因的腺相关病毒载体治疗放射性腮腺功能减退的安全性 04C0165-CCR、NCI的数据收集、临床护理和干预 001572-贝伐珠单抗治疗成人复发性呼吸道乳头状瘤病的II期研究 21C0013:复发性呼吸道乳头状瘤病中的PRGN-2012 20C0024:头颈部鳞状细胞癌的新辅助IO 20C0104:联合免疫在口咽鳞状细胞癌中的表达 000462:天冬氨酸-1929年光免疫疗法 NIDCD临床研究和护理核心每年支持3000多个门诊评估。耳鼻咽喉科核心医生每年要做50-100例大手术。在高级临床助理期间,工作人员指导医学生。耳鼻喉科外科科学家职业发展计划是通过强迫症协调的。
英文摘要
The NIDCD Core for Clinical Research and Care supports the following NIDCD projects: 1 ZIA DC000039 Identification of Genes Causing Syndromic and Nonsyndromic Hearing Impairment 1 ZIA DC000046 Genetic Studies of Human Communications Disorders 1 ZIA DC000060 Molecular Analysis of Human Hereditary Deafness 1 ZIA DC000064 Clinical Analysis of Disorders Of Hearing And Balance 1 ZIA-DC-000082 Neurotology Program 1-ZIA-DC-000088 Cellular and Molecular Pathogenesis of Hearing Restoration in Adult Inner Ear The NIDCD and collaborative protocols supported by the core include: OH93-DC-0016 - Nonsyndromic Hereditary Hearing Impairment Gene Mapping: India / Pakistan Protocol 97-DC-0180 - Genetic Analysis of Human Hereditary Hearing Impairment 01-DC-0228 - Clinical and Molecular Analysis of Hearing Impairment with Enlarged Vestibular Aqueducts 01-DC-0229- Genetic Analysis of Hereditary Disorders of Hearing and Balance 12-DC-0152 - Normative values in audiovestibular testing 17-DC-0138 - Cisplatin and statins in ototoxcity 18-DC-0051 - NIDCD Biospecimens protocol 20-DC-0047 - Natural History and Genome Editing in Dominant Hearing Loss 21-DC-0002- Phase III Interventional Study using Atorvastatin to Reduce Cisplatin-Induced Hearing Loss 21-C-0009 - A Natural History Study of Children and Adults with Olfactory Neuroblastoma 000077 Clinical Data and Specimens in head and neck disorders 000141 Hearing Instability Phenotyping 15-D-0129 Dose-Escalation Study Evaluating the Safety of a Single Administration of an Adeno-Associated Virus Vector Encoding Human Aquaporin-1 in Irradiation-Induced Parotid Salivary Hypofunction 04C0165 - Data Collection, Clinical Care and Interventions in CCR, NCI 001572 - A Phase II Study of Bevacizumab in Adults with Recurrent Respiratory Papillomatosis (RRP) 21C0013: PRGN-2012 in Recurrent Respiratory Papillomatosis 20C0024: Neoadjuvant IO for head and neck squamous cell carcinoma 20C0104: Combo Immunotx in HPV oropharyngeal squamous cell carcinoma 000462: ASP-1929 Photoimmunotherapy The NIDCD Core for Clinical Research and Care supports over 3,000 outpatient clinic evaluations per year. Core otolaryngologists perform 50-100 major surgical cases annually. Staff mentor medical students during senior clinical clerkships. The Otolaryngologist Surgeon Scientist Career Development Program is coordinated through the OCD.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Otologic manifestations of Fanconi anemia and other inherited bone marrow failure syndromes.
范可尼贫血和其他遗传性骨髓衰竭综合征的耳科表现。
DOI: 10.1002/pbc.26155
发表时间: 2016
期刊: Pediatric blood & cancer
影响因子: 3.2
作者: [Kalejaiye,Adedoyin, Giri,Neelam, Brewer,CarmenC, Zalewski,ChristopherK, King,KellyA, Adams,CharleenD, Rosenberg,PhilipS, Kim,HJeffrey, Alter,BlancheP]
通讯作者: Alter,BlancheP
Mechanisms of hearing loss in neurofibromatosis type 2.
2型神经纤维瘤病中听力丧失的机制。
DOI: 10.1371/journal.pone.0046132
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者: [Asthagiri AR, Vasquez RA, Butman JA, Wu T, Morgan K, Brewer CC, King K, Zalewski C, Kim HJ, Lonser RR]
通讯作者: Lonser RR
DOI: 10.1016/j.idcr.2021.e01307
发表时间: 2021
期刊: IDCases
影响因子: 1.5
作者: [Rocco JM, Hammoud DA, Allen CT, Galindo F, Laidlaw E, Sereti I]
通讯作者: Sereti I
DOI: 10.1371/journal.pone.0026639
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者: [Husain FT, Pajor NM, Smith JF, Kim HJ, Rudy S, Zalewski C, Brewer C, Horwitz B]
通讯作者: Horwitz B
共 9 条
    Space Activation for Josh Levy Lab
    海外基金